CompaniesByCap
GYRE
Gyre Therapeutics Inc. (GYRE)
NASDAQ · Healthcare

Gyre Therapeutics Inc. Cash Flow 2009–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Cash Flow1.0M-3.6M25.9M10.7M-83.8M-55.0M-43.6M-28.6M-19.9M-40.6M-64.2M-83.7M138.3M-24.3M
Depreciation & Amort.2.5M1.5M1.1M1.1M290,000138,000146,000149,000173,000974,0002.2M2.5M2.0M1.8M
Investing Activities
Capital Expenditure1.2M2.3M8.5M5.0M839,00064,000376,00023,00041,000333,0001.4M3.3M200,000
Free Cash Flow-180,000-6.0M17.4M5.7M-84.6M-43.7M-28.9M-20.0M-40.7M-64.6M-85.1M135.0M-24.5M
Financing Activities
Dividends Paid45.0M
Stock Buybacks

Gyre Therapeutics Inc. Cash Flow — FAQ

Gyre Therapeutics Inc. (GYRE) cash flow over the last 14 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see GYRE's cash flow history?

The chart and table above show Gyre Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.